"Aged, 80 and over" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A person 80 years of age and older.
| Descriptor ID |
D000369
|
| MeSH Number(s) |
M01.060.116.100.080
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Aged, 80 and over".
Below are MeSH descriptors whose meaning is more specific than "Aged, 80 and over".
This graph shows the total number of publications written about "Aged, 80 and over" by people in this website by year, and whether "Aged, 80 and over" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 40 | 40 |
| 1996 | 0 | 46 | 46 |
| 1997 | 0 | 56 | 56 |
| 1998 | 0 | 55 | 55 |
| 1999 | 0 | 62 | 62 |
| 2000 | 0 | 60 | 60 |
| 2001 | 1 | 65 | 66 |
| 2002 | 0 | 97 | 97 |
| 2003 | 0 | 126 | 126 |
| 2004 | 1 | 123 | 124 |
| 2005 | 0 | 131 | 131 |
| 2006 | 0 | 136 | 136 |
| 2007 | 0 | 141 | 141 |
| 2008 | 0 | 204 | 204 |
| 2009 | 0 | 182 | 182 |
| 2010 | 0 | 195 | 195 |
| 2011 | 0 | 238 | 238 |
| 2012 | 0 | 252 | 252 |
| 2013 | 0 | 300 | 300 |
| 2014 | 0 | 301 | 301 |
| 2015 | 1 | 317 | 318 |
| 2016 | 0 | 347 | 347 |
| 2017 | 0 | 310 | 310 |
| 2018 | 0 | 369 | 369 |
| 2019 | 0 | 365 | 365 |
| 2020 | 0 | 322 | 322 |
| 2021 | 0 | 241 | 241 |
| 2022 | 0 | 70 | 70 |
| 2023 | 0 | 67 | 67 |
| 2024 | 0 | 251 | 251 |
| 2025 | 0 | 192 | 192 |
To return to the timeline,
click here.
Below are the most recent publications written about "Aged, 80 and over" by people in Profiles.
-
Incidence and Management of Adverse Events Associated with Tebentafusp Treatment in Metastatic Uveal Melanoma: Pooled Safety Analysis of 410 Patients. Clin Cancer Res. 2025 Dec 01; 31(23):5027-5036.
-
Stent frame deformation of self-expanding transcatheter heart valves in bicuspid aortic stenosis and impact on valve performance. Eur Heart J Cardiovasc Imaging. 2025 Nov 26; 26(12):1842-1851.
-
Improved technical outcomes with converting thrombectomy techniques after failed first pass recanalization. J Neurointerv Surg. 2025 Nov 18; 17(12):1333-1339.
-
Infection after CD19 chimeric antigen receptor T-cell therapy for large B-cell lymphoma: real-world analysis from CIBMTR. Blood Adv. 2025 Nov 11; 9(21):5460-5472.
-
Influenza Vaccine Effectiveness Against Medically Attended Outpatients Illness, United States, 2023-2024 Season. Clin Infect Dis. 2025 Nov 06; 81(4):e184-e191.
-
RSV Vaccine Effectiveness Against Hospitalization Among US Adults Aged 60 Years or Older During 2 Seasons. JAMA. 2025 Oct 28; 334(16):1442-1451.
-
Validating the California Verbal Learning Test-Second Edition-Short Form Forced Choice Trial as an Embedded Performance Validity Indicator. Arch Clin Neuropsychol. 2025 Oct 19; 40(7):1357-1365.
-
Vaccine Effectiveness Against Influenza A(H1N1), A(H3N2), and B-Associated Hospitalizations, United States, 1 September 2023 to 31 May 2024. J Infect Dis. 2025 Oct 15; 232(4):e626-e636.
-
Long-term follow-up of venetoclax monotherapy in previously treated patients with Waldenstr?m macroglobulinemia. Blood Adv. 2025 Oct 14; 9(19):4842-4847.
-
Patient and Caregiver Outcomes of Health System, Community-Based, and Usual Dementia Care: A Prespecified Analysis of the Dementia Care Study (D-CARE) Randomized Clinical Trial. JAMA Intern Med. 2025 Oct 01; 185(10):1227-1236.